Related Experiment Video

Updated: Apr 25, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Management of insulin pump therapy in children with type 1 diabetes

Nadeem Abdullah1, Claire Pesterfield1, Daniela Elleri2

  • 1Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.

Archives of Disease in Childhood. Education and Practice Edition
|August 16, 2014
PubMed

Insights

Insulin pump therapy offers flexible insulin delivery for children and adolescents with type 1 diabetes. Sensor-augmented pump therapy may further enhance blood glucose control in this age group.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Technology

Background:

  • Type 1 diabetes management in children and adolescents presents unique challenges.
  • Insulin pump therapy (IPT) offers an alternative to multiple daily injections (MDI).

Purpose of the Study:

  • To review the principles and practical management of insulin pump therapy in pediatric patients.
  • To summarize features of available insulin pumps and discuss their advantages and disadvantages.

Main Methods:

  • Review of current literature on insulin pump therapy in pediatric type 1 diabetes.
  • Analysis of features and practical considerations of commercially available insulin pumps.

Main Results:

  • Insulin pumps provide greater flexibility in insulin dosing and meal planning compared to MDI.
  • Sensor-augmented pump therapy, integrating continuous glucose monitoring, shows potential for improved glycemic control.
  • Many young individuals with diabetes successfully integrate insulin pumps into their daily lives.

Conclusions:

  • Insulin pump therapy is a viable and often preferred treatment for pediatric type 1 diabetes.
  • Understanding the practical aspects, benefits, and limitations of pump technology is crucial for effective management.

Keywords:
Insulin PumpsPaediatric PracticeSensorsType 1 Diabetes

More Related Videos

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

4.7K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

64.9K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.2K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
39
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K